Molecular Etiology of Enchondromatosis
Molecular Etiology of Enchondromatosis
批准号:
10431777
负责人:
Benjamin Aaron Alman
金额:
$40.37万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
未结题
起止时间:
2014-09-23 至 2026-06-30
关键词:
AnimalsBenignBinding ProteinsBinding SitesBone neoplasmsCell EnergeticsCell MaintenanceCell SurvivalCell physiologyCellsCholesterolChondrocytesChondrogenic NeoplasmChondromaChondrosarcomaCitric Acid CycleClinicalClinical DataDataDeformityDevelopmentEnchondromatosisEnergy-Generating ResourcesEnzymesEpigenetic ProcessEpiphysial cartilageEtiologyFoundationsGYS1 geneGenesGenetic TranscriptionGlycogenGlycogen (Starch) SynthaseGlycogenolysis InhibitionGrowthHumanHuman Cell LineHyperactivityIn VitroIsocitrate DehydrogenaseIsocitratesKnockout MiceLeadMaintenanceMalignant - descriptorMediatingMediator of activation proteinMetabolicMetabolismMetatarsal bone structureMolecularMusMutant Strains MiceMutationNeoplasmsPainPathological fracturePathologyPatient-Focused OutcomesPharmaceutical PreparationsPharmacologyPhenotypePlayPopulationProcessProductionProliferatingPromoter RegionsProtein phosphataseProteinsRegulationRegulatory ElementRoleSignal PathwaySomatic MutationSourceSterolsTestingTranscriptional ActivationTumor Cell LineWorkXenograft procedurealpha ketoglutaratebasebonecartilage developmentcartilaginouscell growthcholesterol biosynthesisconditional knockouteffective therapyglycogenolysisimprovedinhibitormutantneoplasticneoplastic cellnovelnovel therapeuticsoverexpressionpre-clinicalpreventskeletaltargeted agenttumortumor growthtumor initiation
中文摘要
摘要
超过3%的人患有内生性软骨瘤(ECA),这是一种由细胞组成的骨骼良性肿瘤
从生长板中衍生出来的,会引起疼痛、畸形,并可能导致病理性骨折。
内生性软骨瘤可进展为恶性软骨肉瘤(CSA)。编码异柠檬酸的基因突变
脱氢酶(IDH1和2)在ECA和CSA中占很大比例。在我们之前的工作中,我们
发现IDH突变抑制生长板软骨细胞分化,且软骨细胞特异性条件
IDH1突变小鼠产生ECAs。突变体IDH独特地产生代谢物2-羟基戊二酸(2-HG),但
我们和其他人发现,阻断2-HG的产生在药理上不会改变CsA细胞的活力。
虽然2-HG具有表观遗传效应,这在肿瘤的启动过程中可能是重要的,但肿瘤的维持必须依赖于
其他因素。由于IDH在新陈代谢中起重要作用,相关的代谢变化可能会推动
观察到的表型。我们在表达突变IDH的细胞中发现了高水平的糖原。糖原也是
发现于生长板的增殖和前期肥大细胞中。在我们之前的工作中,我们发现
IDH突变的软骨细胞内胆固醇的生物合成被激活,它也被调节在
生长板,其活性与糖原水平相关。这增加了细胞内
固醇调节元件结合蛋白(SREBP)激活的胆固醇生物合成
转录,也调节糖原。我们的前提是糖原是Pre-Pre的重要能量来源
肥大和肥大的生长板软骨细胞和糖原储存是维持
ECA和CsA的肿瘤表型。我们还提出糖原耗竭可以抑制肿瘤。
表型。在这项建议中,我们将研究是什么调节生长板中的糖原,ECA和CsA,以及
测定这些生长板和肿瘤性软骨细胞中糖原的功能。
为了确定是什么调节生长板、ECA和CsA中的糖原,我们优先考虑了已知的
调节在生长板和IDH突变中差异调节的糖原。蛋白
磷酸酶1调节亚基3C(PPP1R3C)就是这样一个基因,
在其启动子区域包含SREBP结合位点。我们的初步数据表明,SREBP调节
PPP1R3C,然后调节糖原。我们的研究将使用来自人类肿瘤和基因的细胞系
改良内生性软骨瘤小鼠以确定糖原和PPP1R3C在生长中的作用
板块、ECA和CsA。此外,我们还将研究SREBP如何调节PPP1R3C和糖原。糖原
合成酶将被基因删除,或者我们将用抑制糖原合成和分解的药物来抑制细胞。
这些数据将提供临床前信息,为ECA和CsA的新疗法奠定基础。
英文摘要
Abstract
More than 3% of the population develops an enchondroma (ECA), a benign tumor in bone composed of cells
derived from the growth plate that can cause pain, deformity, and can be responsible for pathologic fractures.
Enchondromas can progress to malignant chondrosarcoma (CSA). Mutations in genes encoding isocitrate
dehydrogenase (IDH1 and 2) were identified in a large proportion of ECAs and CSAs. In our prior work, we
found that IDH mutations inhibit growth plate chondrocyte differentiation, and chondrocyte-specific conditional
Idh1 mutant mice develop ECAs. Mutant IDH uniquely produces the metabolite 2-hydroxyglutarate (2-HG), but
we and others found that blocking the production of 2-HG pharmacologically does not alter CSA cell viability.
While 2-HG has epigenetic effects that are likely important in tumor initiation, tumor maintenance must rely on
other factors. Since IDH plays an important role in in metabolism, associated metabolic changes could drive
the observed phenotype. We found high levels of glycogen in cells expressing a mutant IDH. Glycogen is also
found in proliferating and pre-hypertrophic cells of the growth plate. In our previous work, we found that
intracellular cholesterol biosynthesis was activated in IDH mutant chondrocytes and that it is also regulated in
the growth plate, and its activity corelates with glycogen levels. This raises the possibility that intracellular
cholesterol biosynthesis, which is activated by Sterol regulatory-element binding proteins (SREBP)
transcription, also regulates glycogen. Our premise is that glycogen is an important energy source for pre-
hypertrophic and hypertrophic growth plate chondrocytes and that glycogen stores are required to maintain the
neoplastic phenotype in ECA and CSA. We also propose that glycogen depletion can suppress the neoplastic
phenotype. In this proposal we will study what regulates glycogen in the growth plate, ECA and CSA, and
determine the function of glycogen in these growth plate and neoplastic chondrocytes.
To determine what regulates glycogen in the growth plate, ECA, and CSA, we prioritized genes known to
regulate glycogen that were differentially regulated in the growth plate and by IDH mutations. Protein
phosphatase 1 regulatory subunit 3C (PPP1R3C) is one such gene which is differentially and interestingly,
contains SREBP binding sites in its promoter region. Our preliminary data suggest that SREBP regulates
PPP1R3C which then regulates glycogen. Our studies will use cell lines from human tumors and genetically
modified mice that develop enchondromas to define the function of glycogen and PPP1R3C in the growth
plate, ECA, and CSA. In addition, we will study how SREBP regulates PPP1R3C and glycogen. Glycogen
synthase will be deleted genetically, or we will cells with drugs that inhibit glycogen synthesis and breakdown.
This data will provide pre-clinical information on which to base novel therapies for ECA and CSA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting the metastasis initiating cell in undifferentiated pleomorphic sarcoma
-
批准号:10385788
-
项目类别:
-
资助金额:$43.95万
-
财政年份:2021
-
负责人:Benjamin Aaron Alman
-
依托单位:
The role of macrophage subpopulations in the rejuvenation of fracture repair
-
批准号:10544770
-
项目类别:
-
资助金额:$42.93万
-
财政年份:2021
-
负责人:Benjamin Aaron Alman
-
依托单位:
Targeting the metastasis initiating cell in undifferentiated pleomorphic sarcoma
-
批准号:10205287
-
项目类别:
-
资助金额:$48.56万
-
财政年份:2021
-
负责人:Benjamin Aaron Alman
-
依托单位:
Exercise Induced Muscle Secreted Factors That Modify Osteoarthritis (OA) Severity
-
批准号:10302972
-
项目类别:
-
资助金额:$17.71万
-
财政年份:2021
-
负责人:Benjamin Aaron Alman
-
依托单位:
Targeting the metastasis initiating cell in undifferentiated pleomorphic sarcoma
-
批准号:10599999
-
项目类别:
-
资助金额:$43.95万
-
财政年份:2021
-
负责人:Benjamin Aaron Alman
-
依托单位:
The role of macrophage subpopulations in the rejuvenation of fracture repair
-
批准号:10380875
-
项目类别:
-
资助金额:$42.93万
-
财政年份:2021
-
负责人:Benjamin Aaron Alman
-
依托单位:
The role of macrophage subpopulations in the rejuvenation of fracture repair
-
批准号:10201986
-
项目类别:
-
资助金额:$42.93万
-
财政年份:2021
-
负责人:Benjamin Aaron Alman
-
依托单位:
Rejuvenating fracture repair: The role of the macrophage and Beta-catenin
-
批准号:9026036
-
项目类别:
-
资助金额:$37.56万
-
财政年份:2016
-
负责人:Benjamin Aaron Alman
-
依托单位:
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
-
批准号:9319633
-
项目类别:
-
资助金额:$43.56万
-
财政年份:2015
-
负责人:Benjamin Aaron Alman
-
依托单位:
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
-
批准号:9120229
-
项目类别:
-
资助金额:$43.56万
-
财政年份:2015
-
负责人:Benjamin Aaron Alman
-
依托单位:
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
-
批准号:8923215
-
项目类别:
-
资助金额:$42.34万
-
财政年份:2014
-
负责人:Benjamin Aaron Alman
-
依托单位:
Molecular Etiology of Enchondromatosis: Hedgehog Regulation in Chondrocytes
-
批准号:8765722
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2014
-
负责人:Benjamin Aaron Alman
-
依托单位:
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
-
批准号:8815376
-
项目类别:
-
资助金额:$42.79万
-
财政年份:2014
-
负责人:Benjamin Aaron Alman
-
依托单位:
Molecular Etiology of Enchondromatosis
-
批准号:10661035
-
项目类别:
-
资助金额:$40.78万
-
财政年份:2014
-
负责人:Benjamin Aaron Alman
-
依托单位:
Molecular Etiology of Enchondromatosis: Hedgehog Regulation in Chondrocytes
-
批准号:9318429
-
项目类别:
-
资助金额:$34.5万
-
财政年份:2014
-
负责人:Benjamin Aaron Alman
-
依托单位:
海外基金